Australia markets closed

Nanobac Pharmaceuticals, Incorporated (NNBP)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.00000.0000 (0.00%)
As of 01:15PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
Total revenue
17.621
Cost of revenue
14.519
Gross profit
3.102
Operating expenses
Research development
1,149
Selling general and administrative
3,308
Total operating expenses
4,918
Operating income or loss
-4,915
Total other income/expenses net
-1,474
Income before tax
-6,576
Income from continuing operations
-6,576
Net income
-6,576
Net income available to common shareholders
-6,576
Basic EPS
-0.03
Diluted EPS
-0.03
Basic average shares
245,198
Diluted average shares
245,198